- AMGN +0.04%
Search results
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
- 298.62Add to watchlist+0.12 (+0.04%)At close: Fri. Jun 14, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open297.61High299.74Low295.90
- Mkt Cap160.19BP/E (TTM)42.72Div & Yield9.00 & 3.01%
- Prev. Close298.5052 Wk. Low218.4452 Wk. High329.72
What analysts are sayingTop storiesAmgen (AMGN) Stock Sinks As Market Gains: What You Should KnowYahoo Finance · 2 days ago- AMGN +0.04%
Is Amgen Inc (NASDAQ:AMGN) the Top Dividend Stock to Buy in 2024?Yahoo Finance · 4 days ago- AMGN +0.04%
Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical DataYahoo Finance · 4 days agoRelated stocks
Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes.
Amgen is a pioneer in the science of using living cells to make biologic medicines. We helped invent the processes and tools that built the global biotech industry—turning it into a leading source of therapies for patients.
Jan 31, 2023 · reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis, alone or in combination with methotrexate or other non-biologic DMARDs.
Patient Assistance. For reimbursement options and information on help paying for Amgen medications in the U.S., healthcare professionals and patients can also visit amgensupportplus.com.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This...